Roxana Azimi
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- CAR-T cell therapy research
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 4
- Cancer Immunotherapy and Biomarkers 2
- Colorectal Cancer Treatments and Studies 2
- Cancer Cells and Metastasis 1
-
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Hira Rizvi (2 shared papers)Mark M. Awad (2 shared papers)Justin F. Gainor (2 shared papers)Matthew D. Hellmann (2 shared papers)Giulia C. Leonardi (2 shared papers)Jonathan W. Riess (2 shared papers)Mehmet Altan (1 shared paper)Lydia Gedmintas (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Nature (1 paper)Plastic & Reconstructive Surgery Global Open (1 paper)BMJ Case Reports (1 paper)Commentaire (1 paper)
- Partner nations
- United StatesGermanyFinland
In The Last Decade
Roxana Azimi
5 papers receiving 519 citations
Peers
Comparison fields: 5 of 61
- Oncology 320
- Cancer Research 70
- Genetics 41
- Pulmonary and Respiratory Medicine 91
- Immunology 51
Countries citing papers authored by Roxana Azimi
This map shows the geographic impact of Roxana Azimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxana Azimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxana Azimi more than expected).
Fields of papers citing papers by Roxana Azimi
This network shows the impact of papers produced by Roxana Azimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxana Azimi. The network helps show where Roxana Azimi may publish in the future.
Co-authors
The 25 scholars most cited alongside Roxana Azimi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 261 | |
| 2 | 2017 | 251 | |
| 3 | 2017 | 7 | |
| 4 | 2017 | 1 | |
| 5 | 2005 | 1 | |
| 6 | 2021 | 0 | |
| 7 | 2021 | 0 |
About Roxana Azimi
Roxana Azimi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Surgery and Molecular Biology, having authored 7 papers that have together received 521 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (2 papers), Lung Cancer Treatments and Mutations (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Autoimmune and Inflammatory Disorders (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper), Heparin-Induced Thrombocytopenia and Thrombosis (1 paper), Wnt/β-catenin signaling in development and cancer (1 paper) and Cancer Cells and Metastasis (1 paper). The work is most often cited by research in Oncology (320 citations), Cancer Research (70 citations), Genetics (41 citations), Pulmonary and Respiratory Medicine (91 citations) and Immunology (51 citations). Roxana Azimi has collaborated with scholars based in United States, Germany and Finland. Frequent co-authors include Hira Rizvi, Mark M. Awad, Justin F. Gainor, Matthew D. Hellmann, Giulia C. Leonardi, Jonathan W. Riess, Mehmet Altan, Lydia Gedmintas, Sasha Kravets and Suzanne E. Dahlberg. Their work appears in journals such as Journal of Clinical Oncology, Nature, Plastic & Reconstructive Surgery Global Open, BMJ Case Reports and Commentaire.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.